We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current ALLR market cap is 4.5M. The company's latest EPS is USD -4.6048 and P/E is -0.22.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -4.17M | -4.43M | -4.88M | -4.24M | -3.37M |
| Net Income | -9.79M | -5.55M | -1.72M | -3.88M | -1.67M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 |
| Operating Income | -9.23M | -26.56M | -34.46M | -17.13M |
| Net Income | -5.06M | -26.65M | -21.05M | -20.42M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Assets | 13.43M | 13.88M | 11.86M | 11.97M | 30.88M |
| Total Liabilities | 14.15M | 17.25M | 14.61M | 18.44M | 11.05M |
| Total Equity | -723k | -3.38M | -2.75M | -7.98M | 19.84M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 33.4M | 49.63M | 14.54M | 11.86M |
| Total Liabilities | 6.55M | 30.85M | 12.65M | 14.61M |
| Total Equity | 26.85M | 18.15M | -113k | -2.75M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Operating | -5.7M | -11.07M | -12.75M | -1.49M | -8.7M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 4.02M | 10.47M | 11M | 1.38M | 27.69M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -7.25M | -15.05M | -16.82M | -12.75M |
| Investing | -3k | 1M | 791k | N/A |
| Financing | 6.03M | 33.82M | -1.31M | 11M |
| Market Cap | 4.5M |
| Price to Earnings Ratio | -0.22 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 27.01 |
| Price to Book Ratio | -1.63 |
| Dividend Yield | - |
| Shares Outstanding | 4.43M |
| Average Volume (1 week) | 1.18M |
| Average Volume (1 Month) | 476.94k |
| 52 Week Change | -99.69% |
| 52 Week High | 342.00 |
| 52 Week Low | 0.90 |
| Spread (Intraday) | 0.02 (1.96%) |
| Company Name | Allarity Therapeutics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.allarity.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
